血管生成素对糖尿病大鼠股骨头血管新生及渗漏的影响
The effects of Ang-1 on the angiogenesis and vascular leakage of diabetic rats' femoral head
目的 探讨血管生成素1(angi.Poietin-1，Ang-1)对糖尿病大鼠股骨头微血管新生及渗漏的影响。 方法 建立速发型链脲佐菌素（streptozotocin,STZ）糖尿病大鼠模型，随机分为正常5周组 (CON1)、10周组(CON2)及15周组(CON3)，糖尿病5周组（DM1）、10周组（DM2）及15周组（DM3），每组 10只。墨汁灌注观测股骨头微血管密度；摘取模型动物股骨头组织，免疫组化分析凝血因子Ⅷ（FⅧ）表达；原位杂交分析血管内皮生长因子（VEGFmRNA）表达强度；RT-PCR分析Ang-1的mRNA表达。 结果 糖尿病大鼠股骨头随病程发展，Ang-1、FⅧ因子表达上升，与正常组相比有显著性差异（P<0.01）。 VEGFmRNA表达量均高于正常组（P<0.01）；微血管密度加大，显示血管增生、渗漏。 结论 糖尿病股骨头 Ang-1与VEGFmRNA相互协同或拮抗分别促进微血管增生、抗血管渗漏。表达于血管内皮细胞的FⅧ及VEGFmRNA与微血管密度（MVD）变化存在正相关。
Objective To probe into the effects of Ang-1 on the angiogenesis and microvascular leakage of diabetic rats' femoral head. Methods By establishing models of the rats with STZ diabetes, and randomly dividing them into the normal groups (CON1, CON2 and CON3) and the diabetic groups (DM1, DM2 and DM3) with 10 rats each group, the microvascular density through infusion with ink, the expression of blood coagulation factorⅧ with immunohistochemistry, and the expression of the mRNA of both VEGF by hybridization in situ and Ang-1 by RT-PCR, were performed. Results The diabetic rats'femoral head varied in the course of illness. Their expression of Ang-1, blood coagulation factorⅧ, and VEGF mRNA significantly rose, as compared with those of rats in the normal groups(P<0.01). The microvascular density enlarged with vascular proliferation and leakage. Conclusions The interaction and antagonism between Ang-1 and VEGF mRNA of diabetic rats' femoral head can promote microvascular proliferation and resist vascular leakage. The mRNA expression of both coagulation factorⅧ and VEGF in vascular endothelial cells have a positive correlation with the changes of their microvascular density.
糖尿病 / 血管生成素1 / 微血管 / 血管内皮生长因子 / FⅧ因子 / 墨汁灌注 / 原位杂交
Diabetes / Ang-1 / Micrangium / Vascular endothelial growth factor / F-Ⅷ / Infusion with ink / Hybridization in Situ
[1] 陈海英,陈小萍,郑建盛,等.血管内皮生长因子和醛糖还原酶对糖尿病大鼠股骨头结构和微血管形态的影响
[J]. 解剖学报,2009,40(1):157-163．
[2] Goligorsky MS,Jun Chen,Brodsky S.Workshop:endothelial cell dysfunction leading to diabetic nephropathy:focus on nitric oxide
[J].Hypertension,2001,37(2 Part 2):744-748.
[3] Raptis AE,Viberti G.Pathogenesis of diabetic nephropathy
[J].Exp Clin Endocrinol diabetic,2001,109(Suppl 2):S424-437.
[4] Alpert E,Gruzman A,Riahi Y,et al.Delayed autoregulation of glucose transport in vascular endothelial cells
[J]. Diabetologia,2005,48(4):752-755.
[5] Nishikawa T,Edelstein D,Brownlee M.The missing link;a single unifying mechanism for diabetic complications
[J].Kidney Int,2000,77(Suppl):S26-30.
[6] Gerstenfeld LC,Cullinane DM,Barnes GL,et al.Fracture healing as a postnatal developmental process: molecular,spatial,and temporal aspects of its regu- lation
[J].J Cell Biochem,2003,88 (5):873-884.
[7] Abo-Auda W,Benza RL.Therapeutic angiogenesis: review of current concep ts and future directions
[J].J Heart Lung Transplant,2003,22 (4):370-382.
[8] Murphy WL,Simmons CA,Kaigler D,et al.Bone regeneration via a mineral sub- strate and induced angiogenesis
[J].J Dent Res,2004,83(3):204-210.
[9] Zelzer E,McLean W,Ng YS,et al.Skeletal defects in VEGF ( 120 /120 ) mice reveal multipleroles for VEGF in skeletogenesis
[J].Development,2002,129 (8):1893-1904.
[10]Mysliwiec M,Balcerska A,Zorena K,et al.The assessment of the correlation between vascular endothelial growth factor(VEGF),tumor necrosis factor(TNF-alpha),interleukin 6 (IL-6),glycaemic control(HbA1c)and the development of the diabetic retinopathy in children with diabetes mellitus type 1
[J].Klinika Oczna,2007,109(4-6):150-154.
[11]Cui L,Lu H.Alteration of intraocular pigment epithelium-derived factor and vascular endothelial growth factor in patients with diabetic retinopathy
[J].Int J Ophthalmol,2007,7(1):23-26.
[12]Cai J,Kehoe O,Smith GM,et al.The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic reti-nopathy
[J].Invest Ophthalmol Vis Sci,2008,49(5):2163-2171.
[13]Hammes HP,Lin J,Wagner P.Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy
[J].Diabet, 2004,53(4):1104-1110.
[14]Zuo ZF,Liu XZ.Ang/Tie signaling pathways and its effects on the vascularization of retinal capillaries
[J].Int J Ophthalmol(Guo ji Yanke Zazhi), 2006,6(4):857-859.
[15]Kang DH, Anderson S, Kim YG,et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease
[J]. Am J Kidney Diseases,2001,37(3):104-109.
[16]Alon T,Hemo I,Itin A,et al.Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
[J].Nature Med,1995,1(10):1024-1028.
[17]Peter J,Shweiki D,Itin A,et al..Hypoxia-induced expression 0f vascular endothliA1 growth factor by retinal cells is a common factor in neovascularizing ocular diseases
[J].Lab Invest,1995,72(4):638-645.
[18]Takagi H,King GL,Robinson CS, et al. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericyes and endothelial cells
[J].Invest Ophthalmol Vis Sci,1996,37(11):2165-2176.
福建教育厅科研基金资助项目（JB08222）
京ICP备08002354号-3/
| 〈 |
|
〉 |
